|Drug class||Progestin; Progestogen|
ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.
- "ORG 201745 - AdisInsight". adisinsight.springer.com.
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|